SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (103)2/6/1997 1:21:00 PM
From: Michael Collins   of 1115
 
BMY is paying for completion of the clinical trials, but that was before
they dropped the rights for international marketing of Lidakol. I
assume they are still paying for the U.S. trials.

It could very well be Katz that is doing the selling on behalf of MBI.
Back when I used to own and like Lidak, what always impressed me
was that he owned well over 10% of the common stock. I am not
sure of the current figure, though.

Sincerely,

Michael Collins
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News